Aileron Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aileron Therapeutics (ALRN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aileron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aileron Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aileron Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $616 | 93 | 6.63 |
| 2023-12-31 | $6.5k | 2.1k | 3.05 |
| 2023-06-30 | $2.4k | 1.4k | 1.79 |
| 2023-03-31 | $124 | 100 | 1.24 |
| 2022-12-31 | $7.8k | 3.3k | 2.37 |